SecBot SecBot
PRESS-RELEASE ·Filed Jun 2, 2026

PRAX

Praxis Precision Medicines, Inc.
NEUTRAL
Impact 1/10
Horizonimmediate Processed5mo ago WireGlobeNewswire
Press release · Activist
Actionable Insight • Neutral

No trading action warranted. This is a routine equity inducement for new hires with negligible dilution. Monitor upcoming pipeline catalysts (late-stage CNS programs) for material events.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$278.93
T+0 close · Jun 2, 2026 · via day close
Latest settled
+31.88%
T+60 · $367.85
Vs SPY
+29.38%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 3 $278.93entry
  2. T+1 · 6mo ago −5.08%α −5.49% · $264.75
  3. T+5 · 5mo ago −13.72%α −9.90% · $240.66
  4. T+20 · 5mo ago +14.19%α +15.19% · $318.52
  5. T+60 · 3mo ago +31.88%α +29.38% · $367.85
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Praxis Precision Medicines granted 2,754 restricted stock units to 13 new non-executive employees under its 2024 Inducement Plan, a routine equity inducement for new hires. The grant is immaterial in size relative to the company's $9.3B market cap and has no impact on operations or financials.

Key Facts

  • Granted 2,754 RSUs to 13 new non-executive employees under the 2024 Inducement Plan
  • Awards vest in four equal annual installments subject to continued employment
  • Inducement grants are routine and comply with Nasdaq Listing Rule 5635(c)(4)

Financial Impact

2,754 shares granted; immaterial relative to $9.3B market cap

dilution

Risk Factors

  • No material risk from this grant

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
87% bullish (23 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3305570

Track record

16 reports on PRAX

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +15.73% at T+60 after the Jun 29, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $317.69 Now $310.27 +2.34% settles Feb 12
  2. Nov 12, 20264d ago 8-K Neutral 4/10 Entry $328.13 Now $310.27 −5.44% settles Feb 11
  3. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $332.97 Now $310.27 −6.82% settles Feb 5
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $262.59 Now $310.27 +18.16% settles Feb 3
  5. Nov 4, 202612d ago Press Release Neutral 1/10 Entry $262.59 Now $310.27 +18.16% settles Feb 3
  6. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $288.62 Now $310.27 +7.50% settles Jan 27
  7. Jun 29, 202620w ago 8-K Bearish 6/10 Entry $334.79 to $282.12 Now $310.27 +7.32% ▲ +15.73% +18.55% vs SPY
  8. Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $247.98 to $351.81 Now $310.27 +25.12% ▲ +41.87% +37.47% vs SPY
  9. Jun 2, 202623w ago Press Release Neutral 1/10 Viewing Entry $278.93 to $367.85 Now $310.27 +11.24% ▲ +31.88% +29.38% vs SPY
  10. May 7, 202627w ago Press Release Bullish 8/10 Entry $333.28 to $305.51 Now $310.27 −6.90% ▼ −8.33% −12.17% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens Wed (10h 33m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 2, 2026